These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 36701575)

  • 1. An update on expanding HIV preexposure prophylaxis.
    Baker J; Rolls J
    JAAPA; 2023 Feb; 36(2):17-24. PubMed ID: 36701575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cabotegravir Extended-Release Injectable Suspension: A Review in HIV-1 Pre-Exposure Prophylaxis.
    Blair HA
    Drugs; 2022 Sep; 82(14):1489-1498. PubMed ID: 36255686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Acting Injectable Cabotegravir for HIV Preexposure Prophylaxis Among Sexual and Gender Minorities: Protocol for an Implementation Study.
    Grinsztejn B; Torres TS; Hoagland B; Jalil EM; Moreira RI; O'Malley G; Shade SB; Benedetti MR; Moreira J; Simpson K; Pimenta MC; Veloso VG;
    JMIR Public Health Surveill; 2023 Apr; 9():e44961. PubMed ID: 37074775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Propensity to Switch to Long-acting Injectable HIV PrEP with Cabotegravir in a Cohort of Oral PrEP Experienced Men who Have Sex with Men in Italy.
    Raccagni AR; Galli L; Lucente MF; Candela C; Lolatto R; Trentacapilli B; Ponta G; Messina E; Gianotti N; Castagna A; Nozza S
    AIDS Behav; 2024 Mar; 28(3):907-911. PubMed ID: 37792228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges and Opportunities for Preexposure Prophylaxis.
    Cambou MC; Landovitz RJ
    Top Antivir Med; 2021; 29(4):399-406. PubMed ID: 34856093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferences for HIV Preexposure Prophylaxis Products Among Black Women in the U.S.
    Irie WC; Calabrese SK; Patel RR; Mayer KH; Geng EH; Marcus JL
    AIDS Behav; 2022 Jul; 26(7):2212-2223. PubMed ID: 34985607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring preferences and decision-making about long-acting injectable HIV pre-exposure prophylaxis (PrEP) among young sexual minority men 17-24 years old.
    John SA; Zapata JP; Dang M; Pleuhs B; O'Neil A; Hirshfield S; Walsh JL; Petroll AE; Quinn KG
    Sci Rep; 2023 Mar; 13(1):5116. PubMed ID: 36991027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promises and challenges: cabotegravir for preexposure prophylaxis.
    Spinelli MA; Grinsztejn B; Landovitz RJ
    Curr Opin HIV AIDS; 2022 Jul; 17(4):186-191. PubMed ID: 35762372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Projected Impact of Concurrently Available Long-Acting Injectable and Daily-Oral Human Immunodeficiency Virus Preexposure Prophylaxis: A Mathematical Model.
    Maloney KM; Le Guillou A; Driggers RA; Sarkar S; Anderson EJ; Malik AA; Jenness SM
    J Infect Dis; 2021 Jan; 223(1):72-82. PubMed ID: 32882043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-Exposure Prophylaxis (PrEP) Uptake among Black Men Who Have Sex with Men (BMSM) in the Southern U.S.
    Adeagbo O; Harrison S; Qiao S; Li X
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing Gaps in HIV Preexposure Prophylaxis Care to Reduce Racial Disparities in HIV Incidence in the United States.
    Jenness SM; Maloney KM; Smith DK; Hoover KW; Goodreau SM; Rosenberg ES; Weiss KM; Liu AY; Rao DW; Sullivan PS
    Am J Epidemiol; 2019 Apr; 188(4):743-752. PubMed ID: 30312365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term HIV Pre-exposure Prophylaxis Trajectories Among Racial & Ethnic Minority Patients: Short, Declining, & Sustained Adherence.
    Pyra M; Brewer R; Rusie L; Kline J; Willis I; Schneider J
    J Acquir Immune Defic Syndr; 2022 Feb; 89(2):166-171. PubMed ID: 34636809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations of HIV Preexposure Prophylaxis Indications and Uptake, Chicago, Illinois, 2015-2018.
    Pyra M; Rusie LK; Baker KK; Baker A; Ridgway J; Schneider J
    Am J Public Health; 2020 Mar; 110(3):370-377. PubMed ID: 31944849
    [No Abstract]   [Full Text] [Related]  

  • 14. How Has HIV Pre-Exposure Prophylaxis (PrEP) Changed Sex? A Review of Research in a New Era of Bio-behavioral HIV Prevention.
    Grov C; Westmoreland DA; D'Angelo AB; Pantalone DW
    J Sex Res; 2021 Sep; 58(7):891-913. PubMed ID: 34180743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP).
    Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J
    BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NZPrEP Demonstration Project: protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) to determine feasibility, acceptability, adverse and behavioural effects of PrEP provision to gay and bisexual men in publicly funded sexual health clinics in Auckland, New Zealand.
    Azariah S; Saxton P; Franklin R; Forster R; Werder S; Jenkins R
    BMJ Open; 2019 Jun; 9(6):e026363. PubMed ID: 31248921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing HIV Preexposure Prophylaxis Education in a Family Medicine Residency.
    Aurora JA; Ballard SL; Salter CL; Skinker B
    Fam Med; 2022 Mar; 54(3):216-220. PubMed ID: 35303304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of Preexposure Prophylaxis for Human Immunodeficiency Virus Prevention Among Men Who Have Sex With Men at a New England Sexually Transmitted Diseases Clinic.
    Chan PA; Glynn TR; Oldenburg CE; Montgomery MC; Robinette AE; Almonte A; Raifman J; Mena L; Patel R; Mayer KH; Beauchamps LS; Nunn AS
    Sex Transm Dis; 2016 Nov; 43(11):717-723. PubMed ID: 27893604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zero knowledge and high interest in the use of long-acting injectable pre-exposure prophylaxis (PrEP) among adolescent men who have sex with men and transgender women in two capital cities in Brazil.
    Pedrana L; Magno L; Zucchi EM; da Silva LAV; Ferraz D; Grangeiro A; Castellanos M; Brasil SA; Dourado I
    BMC Public Health; 2022 Sep; 22(1):1728. PubMed ID: 36096758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Provision of Preexposure Prophylaxis at the Portuguese National Health Service and Uptake in the Lisbon Cohort of Men Who Have Sex with Men.
    Meireles P; Fernandes F; Rocha M; Plankey M; Barros H
    AIDS Behav; 2021 Jun; 25(6):1975-1983. PubMed ID: 33387137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.